Recent findings published by The American Journal of Managed Care® highlight the benefits of using clascoterone in combination with adapalene for effective acne control. The study reveals that this combination therapy significantly improves acne outcomes, offering a promising alternative to traditional treatments. Clascoterone, a novel hormonal therapy, works by targeting androgen receptors, while adapalene, a well-known retinoid, reduces inflammation and promotes clearer skin. Together, these agents provide comprehensive acne management by addressing both hormonal and inflammatory components of acne. Patients noticed visible improvements in skin texture and reduced acne lesions, showcasing the potential of this regimen as a preferred approach for those struggling with acne. This breakthrough underscores the advancement in dermatological treatments and the ongoing quest for innovation in acne care.
The American Journal of Managed Care® (AJMC®)New data shows nearly 4,400 pediatric surgeries cancelled since 2023
May 11, 2026
A startling revelation from recent national data highlights that nearly 4,400 pediatric surgeries across Ireland were canceled since 2023. The report reveals a concerning pattern